Harmony Biosciences

IPO

Harmony Biosciences & Newrology: A Fresh Approach

Public · Plymouth Meeting, United States · Founded 2017 · $295.0M raised

Employees
201–500
Founded
2017
Business Model
B2B
Total Funding
$295.0M
Last Round
$25.0M Venture RoundJan 2018
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.

About

Harmony Biosciences is a commercial-stage pharmaceutical company founded in 2017 and focused on developing and commercializing innovative therapies for people living with rare neurological diseases. The company received FDA approval for its first product in 2019, went public on NASDAQ in 2020, and has since expanded into rare epilepsy through the acquisitions of Zynerba Pharmaceuticals (2023) and Epygenix Therapeutics (2024). Its Newrology platform integrates patient, family, and scientific perspectives to advance unmet needs in sleep/wake disorders and rare epilepsy.

Summary

Harmony Biosciences is a Biotech company based in Plymouth Meeting, United States, founded in 2017. It has raised $295.0M in total across 2 rounds, most recently a $25.0M Venture Round in Jan 2018. Investors include Valor Equity Partners and Nan Fung Life Sciences.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOJun 2020

Sign up to see all 3 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Harmony Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/harmony-biosciences"><img src="https://indexed.vc/api/badge/company/harmony-biosciences" alt="Harmony Biosciences on Indexed.vc" width="260" height="76" /></a>